Zobrazeno 1 - 10
of 74
pro vyhledávání: '"Stuart Levine"'
Autor:
Olga D’Almeida, Omar Mothar, Esther Apraku Bondzie, Yolande Lieumo, Laure Tagne, Sumeet Gupta, Thomas Volkert, Stuart Levine, Jean-Bosco Tagne
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-24 (2019)
Abstract Background MicroRNAs are noncoding RNA molecules of ~ 22 nucleotides with diagnostic and therapeutic action [Curr Drug Targets, 2015. 16(12): p. 1381-403], affecting the expression of mRNAs involved in invasion, migration, and development [O
Externí odkaz:
https://doaj.org/article/cb5102a447d141d58ff221dae8c59f65
Autor:
Enrico Moiso, Alexander Farahani, Hetal D. Marble, Austin Hendricks, Samuel Mildrum, Stuart Levine, Jochen K. Lennerz, Salil Garg
Publikováno v:
Cancer Discov
Cancer is partly a developmental disease, with malignancies named based on cell or tissue of origin. However, a systematic atlas of tumor origins is lacking. Here we map the single-cell organogenesis of 56 developmental trajectories to the transcript
Autor:
Salil Garg, Jochen K. Lennerz, Stuart Levine, Samuel Mildrum, Austin Hendricks, Hetal D. Marble, Alexander Farahani, Enrico Moiso
Supplementary Table from Developmental Deconvolution for Classification of Cancer Origin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0cbed1ee86baab7edb4d7cb0d9541cde
https://doi.org/10.1158/2159-8290.22541770
https://doi.org/10.1158/2159-8290.22541770
Autor:
Enrico Moiso, Alexander Farahani, Hetal Marble, Austin Hendricks, Samuel Mildrum, Stuart Levine, Jochen Lennerz, Salil Garg
Publikováno v:
Cancer Research. 82:4100-4100
Cancer is a disease manifesting in abrogation of developmental programs, and malignancies are namedbased on their cell or tissue of origin. However, a systematic atlas of tumor origins is lacking. Here we map the single cell organogenesis of 56 devel
Autor:
Alvin H. Shi, Li-Lun Ho, Stuart Levine, Vinod Yadav, Jamie Cheah, Christian Soule, Dennie T. Frederick, David Liu, Genevieve Boland, Manolis Kellis
Publikováno v:
Cancer Research. 79:948-948
The development of immune checkpoint inhibitors (ICI) has revolutionized treatment for numerous cancer types. However, a significant fraction (~45%) of patients treated with ICI fail to exhibit a sustainable clinical response to the drug. A number of
Publikováno v:
Hospital Pharmacy. 48:282-301
Significant patient safety incidents related to sterile drug compounding have occurred for many years. Previous guidelines have focused on ensuring sterility, but serious compounding errors have occurred as well. National efforts are needed to identi
Autor:
Stuart Levine, Rabih Dabliz
Publikováno v:
American Journal of Perinatology. 29:49-56
Newborn intensive care units (NICUs) are high-risk areas of care, where complex medical interventions are performed, and are recognized as a resource for improved outcome in premature and low-birth-weight infants or those presenting with acute condit